表紙
市場調查報告書

胞外體研究用產品的全球市場分析、預測 (∼2024年):套件、試劑、設備、服務

Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 800066
出版日期 內容資訊 英文 128 Pages
訂單完成後即時交付
價格
Back to Top
胞外體研究用產品的全球市場分析、預測 (∼2024年):套件、試劑、設備、服務 Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024
出版日期: 2019年02月27日內容資訊: 英文 128 Pages
簡介

全球胞外體研究用產品的市場在預測期間內預測將以23.8%的年複合成長率 (CAGR) 發展,從2019年的9100萬美元,擴大到2024年2億6400萬美元的規模。對生命科學研究的資金投入的擴大,癌症的高盛行率,胞外體為基礎的診斷、對治療的高度關注等要素促進該市場的成長。可是持有技術的專家不足預計成為今後成長的障礙。

本報告提供全球胞外體研究用產品的市場調查,市場定義和概要,市場成長的各種影響因素及市場機會分析,各產品、服務、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要、產業趨勢

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 胞外體研究用產品市場分析、預測:各產品、服務

  • 簡介
  • 套件、試劑
  • 設備
  • 服務

第7章 胞外體研究用產品市場分析、預測:各用途

  • 簡介
  • 癌症
    • 肺癌
    • 乳癌
    • 前列腺癌
    • 大腸癌
    • 其他
  • 非癌症用途

第8章 胞外體研究用產品市場分析、預測:各終端用戶

  • 簡介
  • 學術、研究機關
  • 醫藥品、生物科技企業
  • 醫院、臨床檢驗實驗室

第9章 胞外體研究用產品市場分析、預測:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞洲
    • 中國
    • 日本
    • 其他
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第11章 企業簡介

  • BIO-TECHNE
  • THERMO FISHER SCIENTIFIC INC.
  • SYSTEM BIOSCIENCES (SBI)
  • NX PHARMAGEN
  • QIAGEN N.V.
  • MILTENYI BIOTECH
  • AMS BIOTECHNOLOGY LTD.
  • NANOSOMIX
  • LONZA GROUP AG
  • NORGEN BIOTEK CORP.

第12章 附錄

目錄
Product Code: BT 6939

"High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products market"

The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market to a certain extent in the coming years.

"The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period"

Based on end user, the exosomes research products market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to significant investments by companies in research activities for the development of exosome-based diagnostics to combat new diseases.

"The lung cancer segment accounted for the largest share of the exosome research products market during the forecast period"

Based on cancer applications, the exosomes research products market is segmented into lung, prostate, breast, colorectal, and other cancers. In 2018, lung cancer accounted for the largest share of the exosomes market for cancer applications. The large share of this segment can primarily be attributed to factors such as the increasing prevalence of lung cancer, technological advancements in instruments & assays for liquid biopsy, and the growing demand for advanced diagnostic technologies.

"North America to dominate the market during the forecast period"

In 2018, North America accounted for the largest share of the exosome research products market. The North American market is also expected to grow at the highest CAGR during the forecast period. Factors such as the availability of government funding for life science research, favorable regulatory environment, increasing focus on exosomes in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research are driving the growth of the exosomes market in North America. According to R&D Magazine (2018), North America accounted for 27.36% of global R&D spending. North America has several national institutes that support biotechnology and life science research activities. The growth of the biotechnology and pharmaceutical industries and growth in the number of cancer cases in the region are also supporting market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (55%), Tier 2 (20%), and Tier 3 (25%)
  • By Designation: C-level (58%), D-level (19%), and Others (23%)
  • By Region: North America (40%), Europe (30%), Asia (10%), and RoW (20%)

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific (US)
  • QIAGEN N.V. (Netherlands)
  • Lonza (Switzerland)
  • Bio-Techne (US)
  • System Biosciences, LLC. (US)
  • NX Pharmagen (US)
  • Miltenyi Biotec (Germany)
  • AMS Biotechnology (Europe) Limited (UK)
  • NanoSomiX (US)
  • Norgen Biotek Corp. (Canada)

Research Coverage:

This report provides a detailed picture of the global exosome research products market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research products market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. EXOSOMES MARKET: OVERVIEW
  • 4.2. EXOSOMES MARKET, BY APPLICATION, 2019-2024(USD MILLION)
  • 4.3. EXOSOME MARKET SHARE, BY CANCER APPLICATIONS & REGION (2018)
  • 4.4. EXOSOME MARKET, BY END USER, 2019 VS. 2024(USD MILLION)
  • 4.5. EXOSOME MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing funding for life sciences research
      • 5.2.1.2. High global prevalence of cancer
      • 5.2.1.3. Increasing interest in exosome-based procedures
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of skilled professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Untapped emerging markets
      • 5.2.3.2. Growing interest in exosome-based therapeutics
      • 5.2.3.3. Personalized medicine

6. EXOSOMES MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. KITS AND REAGENTS
    • 6.2.1. KITS AND REAGENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE EXOSOMES MARKET DURING THE FORECAST PERIOD
  • 6.3. INSTRUMENTS
    • 6.3.1. INCREASE IN THE NUMBER OF DIAGNOSTIC LABORATORIES OFFERING EXOSOME-BASED TESTS TO DRIVE THE ADOPTION OF INSTRUMENTS
  • 6.4. SERVICES
    • 6.4.1. EXOSOME SERVICES AID ONCOLOGISTS TO DETECT AND MONITOR CANCER BIOMARKERS FROM A SIMPLE BLOOD OR URINE SAMPLE

7. EXOSOMES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CANCER APPLICATIONS
    • 7.2.1. LUNG CANCER
      • 7.2.1.1. Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth
    • 7.2.2. BREAST CANCER
      • 7.2.2.1. High prevalence of breast cancer and increasing awareness to drive the market for this segment
    • 7.2.3. PROSTATE CANCER
      • 7.2.3.1. Liquid biopsy helps detect aggressive prostate cancer before surgery-a key factor driving market growth
    • 7.2.4. COLORECTAL CANCER
      • 7.2.4.1. Increasing research activities and projects based on exosomes to drive the market for this segment
    • 7.2.5. OTHER CANCERS
      • 7.2.5.1. Rising incidence of cancer and increasing research funding to drive the market for this segment
  • 7.3. NON-CANCER APPLICATIONS
    • 7.3.1. WIDE RANGE OF NON-CANCER APPLICATIONS TO DRIVE GROWTH IN THE DEMAND FOR EXOSOMES IN THIS APPLICATION SEGMENT

8. EXOSOMES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. ACADEMIC & RESEARCH INSTITUTES
    • 8.2.1. ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN THE EXOSOMES MARKET
  • 8.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.3.1. SIGNIFICANT DEVELOPMENTS IN RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT
  • 8.4. HOSPITALS & CLINICAL TESTING LABORATORIES
    • 8.4.1. HOSPITALS & CLINICAL TESTING LABORATORIES USE EXOSOMES FOR THE DIAGNOSIS OF CANCER

9. EXOSOMES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. High burden of cancer and favorable public and private funding for research activities to drive market growth
    • 9.2.2. CANADA
      • 9.2.2.1. Availability of research funding & rising incidence of cancer to drive market growth
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Presence of a large number of academic research institutes to support market growth
    • 9.3.2. UK
      • 9.3.2.1. Growth in the life sciences industry to drive the market for exosomes in the UK
    • 9.3.3. FRANCE
      • 9.3.3.1. Government initiatives to boost R&D activities in the country and high healthcare expenditure are the key factors driving market growth
    • 9.3.4. ROE
  • 9.4. ASIA
    • 9.4.1. CHINA
      • 9.4.1.1. Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are the major factors driving market growth
    • 9.4.2. JAPAN
      • 9.4.2.1. High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosomes market in the country
    • 9.4.3. REST OF ASIA
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. PARTNERSHIPS AND AGREEMENTS (2016-2019)
    • 10.3.2. PRODUCT LAUNCHES (2016-2019)
    • 10.3.3. ACQUISITIONS (2016-2019)
    • 10.3.4. EXPANSIONS (2016-2019)
  • 10.4. COMPETITIVE LEADERSHIP MAPPING (2017)
    • 10.4.1. VANGUARDS
    • 10.4.2. INNOVATORS
    • 10.4.3. DYNAMIC PLAYERS
    • 10.4.4. EMERGING PLAYERS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. BIO-TECHNE
  • 11.2. THERMO FISHER SCIENTIFIC INC.
  • 11.3. SYSTEM BIOSCIENCES (SBI)
  • 11.4. NX PHARMAGEN
  • 11.5. QIAGEN N.V.
  • 11.6. MILTENYI BIOTECH
  • 11.7. AMS BIOTECHNOLOGY LTD.
  • 11.8. NANOSOMIX
  • 11.9. LONZA GROUP AG
  • 11.10. NORGEN BIOTEK CORP.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL CANCER INCIDENCE, 2018 VS. 2025
  • TABLE 2: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 3: EXOSOMES MARKET FOR KITS AND REAGENTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: EXOSOMES MARKET FOR INSTRUMENTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: EXOSOMES MARKET FOR SERVICES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 7: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 8: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: EXOSOMES MARKET FOR LUNG CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: EXOSOMES MARKET FOR BREAST CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: EXOSOMES MARKET FOR PROSTATE CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: EXOSOMES MARKET FOR COLORECTAL CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: EXOSOMES MARKET FOR OTHER CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: EXOSOMES MARKET FOR NON-CANCER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 16: EXOSOMES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: EXOSOMES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: EXOSOMES MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: EXOSOMES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: EXOSOMES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: NORTH AMERICA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 25: US: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 26: US: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 27: US: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 28: US: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 29: CANADA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 30: CANADA: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 31: CANADA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 32: CANADA: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: EXOSOMES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 36: EUROPE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38: GERMANY: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 39: GERMANY: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 40: GERMANY: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 41: GERMANY: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 42: UK: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 43: UK: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 44: UK: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45: UK: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: FRANCE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 47: FRANCE: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 48: FRANCE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: FRANCE: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 50: ROE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 51: ROE: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 52: ROE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53: ROE: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 54: ASIA: EXOSOMES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 55: ASIA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 56: ASIA: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 57: ASIA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58: ASIA: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 59: CHINA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 60: CHINA: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 61: CHINA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: CHINA: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 63: JAPAN: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 64: JAPAN: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 65: JAPAN: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: JAPAN: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 67: ROA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 68: ROA: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 69: ROA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 70: ROA: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: ROW: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: ROW: EXOSOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 73: ROW: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: ROW: EXOSOMES MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: EXOSOMES MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: EXOSOMES MARKET, BY APPLICATION, 2019 (USD MILLION)
  • FIGURE 9: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: EXOSOMES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE EXOSOMES MARKET
  • FIGURE 12: HIGH GLOBAL BURDEN OF CANCER & INCREASING FUNDING FOR LIFE SCIENCE RESEARCH ARE DRIVING THE GROWTH OF THE EXOSOME MARKET
  • FIGURE 13: NON-CANCER APPLICATION SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: LUNG CANCER SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 15: ACADEMIC & RESEARCH INSTITUTES TO HOLD THE LARGEST SHARE OF THE EXOSOME MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: NORTH AMERICA IS THE FASTEST-GROWING REGION IN THE EXOSOME MARKET
  • FIGURE 17: EXOSOMES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 18: KITS AND REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE EXOSOME PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: CANCER APPLICATIONS SEGMENT TO DOMINATE EXOSOMES MARKET DURING THE FORECAST PERIOD (2019-2024)
  • FIGURE 20: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICA: EXOSOMES MARKET SNAPSHOT
  • FIGURE 22: US: CANCER STATISTICS
  • FIGURE 23: CANADA: CANCER STATISTICS
  • FIGURE 24: EUROPE: EXOSOMES MARKET SNAPSHOT
  • FIGURE 25: ASIA: EXOSOMES MARKET SNAPSHOT
  • FIGURE 26: ROW: EXOSOMES MARKET SNAPSHOT
  • FIGURE 27: KEY DEVELOPMENTS IN THE EXOSOMES MARKET (JAN 2016-JAN 2019)
  • FIGURE 28: MARKET EVOLUTION FRAMEWORK
  • FIGURE 29: EXOSOMES MARKET RANKING ANALYSIS, BY KEY PLAYER (2017)
  • FIGURE 30: MNM DIVE-VENDOR COMPARISON MATRIX: EXOSOMES MARKET
  • FIGURE 31: COMPANY SNAPSHOT: BIO-TECHNE
  • FIGURE 32: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC
  • FIGURE 33: COMPANY SNAPSHOT: QIAGEN N.V.
  • FIGURE 34: LONZA GROUP AG: COMPANY SNAPSHOT
Back to Top